0000950170-24-024222.txt : 20240301
0000950170-24-024222.hdr.sgml : 20240301
20240301195252
ACCESSION NUMBER: 0000950170-24-024222
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH WAYNE T
CENTRAL INDEX KEY: 0001018660
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15925
FILM NUMBER: 24712427
MAIL ADDRESS:
STREET 1: 500 WEST MAIN STREET
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC
CENTRAL INDEX KEY: 0001108109
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 133893191
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-465-7000
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/
DATE OF NAME CHANGE: 20000229
4
1
ownership.xml
4
X0508
4
2024-03-01
0001108109
COMMUNITY HEALTH SYSTEMS INC
CYH
0001018660
SMITH WAYNE T
4000 MERIDIAN BOULEVARD
FRANKLIN
TN
37067
true
false
false
false
false
Common Stock
2024-03-01
4
M
false
144000
0
A
5227075
D
Common Stock
1606842
I
by The Modified 2009 WTS Irrev Trust Dated 12/16/22
Common Stock
481721
I
WAC LLC
Performance Based Restricted
0
2024-03-01
4
M
false
144000
0
D
Common Stock
144000
36000
D
Performance Based Restricted
0
2024-03-01
4
D
false
36000
0
D
Common Stock
36000
0
D
Restricted Stock Units
0
2024-03-01
4
A
false
62718
2.87
A
Common Stock
62718
62718
D
Restricted Stock Units
0
2024-03-01
4
A
false
92334
2.87
A
Common Stock
92334
92334
D
Performance Based Restricted
0
Common Stock
180000
180000
D
Restricted Stock Units
0
Common Stock
29268
29268
D
Restricted Stock Units
0
Common Stock
43089
43089
D
Stock Options (Right to Buy)
4.99
2020-03-01
2029-02-28
Common Stock
78750
78750
D
Stock Options (Right to Buy)
4.93
2021-03-01
2030-02-28
Common Stock
112500
112500
D
Stock Options (Right to Buy)
8.81
2022-03-01
2031-02-28
Common Stock
90000
90000
D
Stock Options (Right to Buy)
10.18
2023-03-01
2032-02-29
Common Stock
90000
90000
D
Stock Units (SU)
0
Common Stock
35609.301
35609.301
D
The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (144,000), and the remaining 20% of the target number has been forfeited (36,000).
The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.
The restricted stock units, which were granted as payment of the Reporting Person's additional annual stipend for serving as the Chair of the Board, vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person.
Christopher G. Cobb, Attorney in Fact for Wayne T. Smith
2024-03-01